Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126615472 | 12661547 | 2 | F | 201602 | 20160816 | 20160817 | 20160822 | PER | US-PFIZER INC-2016365369 | PFIZER | 67.00 | YR | F | Y | 0.00000 | 20160822 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126615472 | 12661547 | 1 | PS | AROMASIN | EXEMESTANE | 1 | 25 MG, UNK | 708BH | 20753 | 25 | MG | COATED TABLET | |||||||
126615472 | 12661547 | 2 | C | CARVEDILOL. | CARVEDILOL | 1 | 6.25 MG, UNK | 0 | 6.25 | MG | |||||||||
126615472 | 12661547 | 3 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
126615472 | 12661547 | 4 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 10 MEQ, UNK (ER) | 0 | 10 | MEQ |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126615472 | 12661547 | 1 | Breast cancer |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126615472 | 12661547 | Asthenia | |
126615472 | 12661547 | Headache | |
126615472 | 12661547 | Hyperhidrosis | |
126615472 | 12661547 | Increased appetite | |
126615472 | 12661547 | Weight loss poor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126615472 | 12661547 | 1 | 201602 | 0 |